Thorne Quercetin Phytosome
250 mg quercetin phytosome per capsule
Quercetin phytosome capsules.
Best for: comparing a quercetin phytosome option in Key Facts
View on Amazon · Affiliate link
Quercetin inhibits DNA methyltransferases (DNMTs), activates SIRT1 histone deacetylase, and modulates histone acetyltransferase activity — collectively producing epigenetic changes that may partially reverse aging-associated methylation patterns. The implications for biological age clocks (Horvath clock) and aging rate are being actively studied.
As an Amazon Associate, Stacking Years earns from qualifying purchases.
250 mg quercetin phytosome per capsule
Quercetin phytosome capsules.
Best for: comparing a quercetin phytosome option in Key Facts
View on Amazon · Affiliate link
Can quercetin reduce biological age as measured by methylation clocks?
There are no published clinical studies measuring epigenetic age clock changes from quercetin supplementation alone. The mechanistic pathways (DNMT inhibition, SIRT1 activation) are directly relevant, but quantitative effects in humans are unknown.
Is quercetin's SIRT1 activation as strong as resveratrol's?
Resveratrol's SIRT1 activation has been extensively studied and debated. Quercetin's SIRT1 activation appears real but less studied in humans. The combination of quercetin + NMN (providing NAD+ substrate) may be more effective than either compound's SIRT1 effects alone.
How long should I take quercetin for epigenetic effects?
Epigenetic changes occur gradually over weeks to months of consistent supplementation. Minimum 3–6 months of regular use is suggested before evaluating epigenetic effects.
DNA methylation and histone changes are complex and tissue-specific; changing a laboratory marker does not necessarily improve health. Human evidence must show that the same preparation changes a meaningful outcome with acceptable safety. Avoid using unvalidated epigenetic tests to select supplement doses or claim that biological age has been reversed.
A plausible mechanism is a reason to study an intervention, not proof of a clinical benefit. Separate laboratory findings from human outcomes, and do not infer that a biomarker change means a disease was prevented or aging was slowed. Before acting, define the question, check interactions and product labeling, and seek professional assessment for persistent or serious symptoms.